Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).
A major concern with using antiretroviral (ARV)-based products for HIV prevention is the potential spread of drug resistance, particularly from individuals who are HIV-infected but unaware of their status. Limited data exist on the prevalence of HIV infection or drug resistance among potential users...
Main Authors: | Urvi M Parikh, Photini Kiepiela, Shayhana Ganesh, Kailazarid Gomez, Stephanie Horn, Krista Eskay, Cliff Kelly, Barbara Mensch, Pamina Gorbach, Lydia Soto-Torres, Gita Ramjee, John W Mellors, MTN-009 Protocol Team, IPTc Taskforce |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3621859?pdf=render |
Similar Items
-
Correction: Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009)
by: Urvi M. Parikh, et al.
Published: (2014-01-01) -
Correction: Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009).
by: Urvi M. Parikh, et al.
Published: (2014-01-01) -
Understanding women’s motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence
by: Ariana W. K. Katz, et al.
Published: (2019-01-01) -
Management of an HIV/AIDS wellness programme : a case study of the HIV Your life programme
by: Ganesh, Shayhana
Published: (2017) -
PIMA<sup>TM</sup> point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa
by: Mandisa Skhosana, et al.
Published: (2016-06-01)